ProfileGDS5678 / 1421532_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 5% 5% 5% 5% 5% 5% 5% 5% 5% 5% 5% 5% 5% 5% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.081045
GSM967853U87-EV human glioblastoma xenograft - Control 22.062065
GSM967854U87-EV human glioblastoma xenograft - Control 32.065545
GSM967855U87-EV human glioblastoma xenograft - Control 42.019475
GSM967856U87-EV human glioblastoma xenograft - Control 52.008395
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.103255
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.086365
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.037715
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.032795
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.048525
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.047375
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.038235
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.054545
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.052935